Hairloss treatments like Minoxidil, finasteride, and potential mRNA therapies are discussed. There is skepticism about targeting specific genes due to the complex genetic nature of hairloss.
Hairloss treatments are being tested on mice, with methods like minoxidil and stem cell therapy showing promising results. However, human trials are still years away, leading to humorous frustration about mice benefiting first.
Hairloss changes are typically noticed over months or years, not days, and treatments like finasteride, dutasteride, and minoxidil require time to show effects. People often overreact to daily shedding, but realistic expectations and patience are necessary for hair regrowth treatments.
Hairloss may be linked to the TRPS1 gene and protein, not just DHT. Amplifica's AMP-303 targets mesenchymal stem cells and shows promise in treating hairloss, unlike Pelage's PP405.
Hairloss returned after 8 months of using a treatment with .3% Dutasteride and 8% Minoxidil. The user suspects a marketing strategy as the company offers a more expensive product with additional ingredients like biotin and finasteride.
Hairloss has slowed or stopped after 5 months of daily oral minoxidil and finasteride treatment, with ketoconazole shampoo used twice a week. Noticeable thickening is observed, especially on the mid scalp.
Finasteride and Dutasteride do not cause depression or mood disorders; hairloss itself may be a more significant factor. Some users experience side effects from Finasteride, but it is generally well-tolerated.
Lowering DHT can improve skin quality and reduce scalp issues. Finasteride is effective for hair regrowth and improving skin texture, while dutasteride may increase oiliness and shedding for some users.
Hairloss requires proper diagnosis as it can have various causes, and treatments like finasteride, minoxidil, and dutasteride are often used. Many people express frustration with dermatologists and turn to self-research and alternative sources for treatment.
Hairloss is linked to a higher rate of body dysmorphic disorder (BDD), OCD, and depression. Finasteride and dutasteride are not linked to increased suicidal risk, though some users report mental health side effects.
Hair growth relies on mechanical forces, not just chemicals, with tissue acting like a motor. Minoxidil and finasteride help, but maintaining tissue elasticity and addressing mechanical issues are essential.
Hairloss affects mental health and self-esteem, causing anxiety and depression. Treatments like finasteride, minoxidil, and hair transplants help some, but others continue to struggle.
Hairloss was triggered by a testosterone and Masteron cycle, causing scalp tension and shedding. Topical finasteride, RU58841, and oral minoxidil were used to stop shedding and improve scalp condition.
Rapid weight loss may have triggered increased hair shedding. Continuing with finasteride, microneedling, a healthy diet, and supplements like MSM and vitamin B is advised, but results may take 6-12 months.
Hairloss is often linked to inflammation and DHT, with treatments like finasteride, dutasteride, and minoxidil being effective for many. Natural remedies like turmeric and oils are discussed, but medications are generally seen as more reliable for managing genetic hairloss.
The user experienced significant hair shedding after using a dermapen at 1.5mm weekly, which they later realized was too much. They are now using a dermapen at 0.75mm weekly and are also using topical minoxidil twice daily and finasteride 1.25mg daily.
COVID and COVID vaccination can trigger hairloss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.
Topical roflumilast is effective for reducing inflammation in various scalp conditions like seborrheic dermatitis, psoriasis, and eczema, but not proven to stop scarring alopecia. Alternatives like apremilast and Vtama are also discussed for their anti-inflammatory benefits.
The conversation is about a hairloss treatment plan involving finasteride, minoxidil, microneedling, GHK-CU injections, Nizoral shampoo, and RU58841. The user is advised to start with a simpler regimen to minimize side effects and assess effectiveness before adding more treatments.
A 33-year-old experienced significant hairloss after a depressive episode and taking paroxetine, possibly due to telogen effluvium or androgenic alopecia. Suggestions included reducing alcohol, considering finasteride and minoxidil, and consulting a doctor about antidepressant side effects.
The user shared their hairloss journey, using Minoxidil 2%, Serenoa repens, topical finasteride, a topical antiandrogen, Vitamin D, and lifestyle changes, noting improvements but still seeking more density. They are considering switching to Minoxidil 5% but prefer focusing on finasteride and antiandrogen for better results.
People shared their experiences with coffee consumption and hairloss, with mixed results. Some noticed more hairloss with increased caffeine, while others saw no effect or even hair regrowth, often using treatments like finasteride and minoxidil.
A 26-year-old male is using oral minoxidil and finasteride to treat hairloss, experiencing prolonged shedding despite 6 months of treatment. Others share similar experiences, suggesting persistence with the treatment may eventually lead to improvement.
Hairloss is linked to scalp fibrosis and tension, which result from chronic mechanical stress and androgenic signaling. Treatments include blocking androgens with finasteride, promoting hair growth with topical minoxidil, and improving scalp mobility through exercises.
South Korea's president is advocating for hereditary hairloss to be covered by national health insurance due to its impact on mental health and daily functioning. The discussion highlights the societal pressure in South Korea regarding appearance and the potential benefits of treating hairloss to improve mental health.
A user is considering starting treatments like Finasteride, Minoxidil, and Microneedling for hair thinning, despite stable hairloss for over 8 years. They are unsure if the presence of miniaturized hairs indicates potential for regrowth or if they should accept the current state.
Hair growth success may be linked to addressing scalp fungi issues, with treatments like minoxidil, finasteride, and dutasteride being important. DHT may contribute to scalp microbial issues, potentially causing inflammation and hairloss.
Hairloss greatly affects mental health and social life for young men. Treatments like finasteride, minoxidil, and hair transplants are common, with mixed success and ongoing self-esteem challenges.
The user shared their hairloss journey, using finasteride, dutasteride, and minoxidil, noting progress and some side effects like minor gynecomastia. They plan to switch fully to dutasteride while continuing minoxidil, and they experienced shedding primarily from finasteride.
Hairloss may be linked to blood flow issues, but DHT is considered the main cause. Treatments used include finasteride, RU58841, minoxidil, vitamin D3, microneedling, and dutasteride, but hairloss persists.